Aragen funding, investors and company details

Aragen is an emerging Pharmaceutical startup from Hyderabad, working in the space of Global R&D and manufacturing solutions provider for the life sciences industry. Founded by Manni Kantipudi.

Company: Aragen Life Sciences Limited
Sector: Pharmaceutical
Location: Hyderabad
Founders: Manni Kantipudi
Total funding raised: ₹865.6 Cr

Company overview

Aragen Life Sciences is a global R&D and manufacturing solutions provider for the life sciences industry, founded in 2001. Aragen positions itself as a trusted partner across the drug development continuum, offering services from early-stage discovery to clinical development and commercial manufacturing. Its expertise spans small and large molecules, catering to pharma, biotech, agrochemical, and animal health companies. The company emphasizes an innovation-driven approach, combining enabling technologies with a strong partnership mindset to deliver end-to-end or standalone solutions. This flexibility allows Aragen to support clients at every stage of the biopharma lifecycle. With over 20 years of experience, Aragen has built credibility as a reliable outsourcing partner in drug discovery and development. Aragen’s long-term vision is to be a global leader in contract research and manufacturing, transforming client ideas into solutions for better health while maintaining affordability and innovation

Funding rounds

Latest round: $ 100.00 Mn (₹865.60 Cr.), 2025-01-14. Investors: Quadria Capital